Electro-mechanical dysfunction in long QT syndrome: Role for arrhythmogenic risk prediction and modulation by sex and sex hormones

Progress in Biophysics and Molecular Biology

Volumn 120, Issue 1-3, 2016, Pages 255-269

  Lang, C N ^a   Menza, M ^b   Jochem, S ^a   Franke, G ^a   Perez Feliz, S ^a   Brunner, M ^a   Koren, G ^c   Zehender, M ^a   Bugger, H ^a   Jung, B A ^b,d   Foell, D ^a   Bode, C ^a   Odening, K E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cardiac repolarization; Contraction duration; Diastolic relaxation; Long QT syndrome; Mechanical dysfunction; Sex hormones

Indexed keywords

SEX HORMONE;

ACTION POTENTIAL; ANIMAL; BIOMECHANICS; BLOOD; ELECTROPHYSIOLOGY; FEMALE; LONG QT SYNDROME; MALE; MECHANICS; PATHOLOGY; PATHOPHYSIOLOGY; RABBITS AND HARES; RISK; SEXUAL DEVELOPMENT;

ACTION POTENTIALS; ANIMALS; BIOMECHANICAL PHENOMENA; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; GONADAL STEROID HORMONES; LONG QT SYNDROME; MALE; MECHANICAL PHENOMENA; RABBITS; RISK; SEX CHARACTERISTICS;

EID: 84953286920     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2015.12.010     Document Type: Article

References (90)

1. Abildskov J.A. Neural mechanisms involved in the regulation of ventricular repolarization. Eur. Heart J. 1985, 6(Suppl. D):31-39.
2. Ando F., Kuruma A., Kawano S. Synergic effects of β-estradiol and erythromycin on hERG currents. J. Membr. Biol. 2011, 241:31-38. 10.1007/s00232-011-9360-z.
3. Anneken L., Baumann S., Vigneault P., Biliczki P., Friedrich C., Xiao L., Girmatsion Z., Takac I., Brandes R.P., Kissler S., Wiegratz I., Zumhagen S., Stallmeyer B., Hohnloser S.H., Klingenheben T., Schulze-Bahr E., Nattel S., Ehrlich J.R. Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking. Eur. Heart J. 2015, ehv371. 10.1093/eurheartj/ehv371.
4. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2024-H2038. 10.1152/ajpheart.00355.2007.
5. Antzelevitch C. Cardiac repolarization. The long and short of it. Europace 2005, 7:S3-S9. 10.1016/j.eupc.2005.05.010.
6. Bassani R.A. Transient outward potassium current and Ca2+ homeostasis in the heart: beyond the action potential. Braz. J. Med. Biol. Res. 2006, 39:393-403.
7. Bauer R.W., Radtke I., Block K.T., Larson M.C., Kerl J.M., Hammerstingl R., Graf T.G., Vogl T.J., Zhang S. True real-time cardiac MRI in free breathing without ECG synchronization using a novel sequence with radial k-space sampling and balanced SSFP contrast mode. Int. J. Cardiovasc Imaging 2013, 29:1059-1067. 10.1007/s10554-013-0183-0.
8. Bekke, ter R.M.A., Haugaa K.H., van den Wijngaard A., Bos J.M., Ackerman M.J., Edvardsen T., Volders P.G.A. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk. Eur. Heart J. 2015, 36:179-186. 10.1093/eurheartj/ehu370.
9. Benhorin J., Moss A.J., Bak M., Zareba W., Kaufman E.S., Kerem B., Towbin J.A., Priori S., Kass R.S., Attali B., Brown A.M., Ficker E. Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations. Ann. Noninvasive Electrocardiol. 2002, 7:40-46.
10. Bentzen B.H., Bahrke S., Wu K., Larsen A.P., Odening K.E., Franke G., Storm vańs Gravesande K., Biermann J., Peng X., Koren G., Zehender M., Bode C., Grunnet M., Brunner M. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. J. Cardiovasc. Pharmacol. 2011, 57:223-230. 10.1097/FJC.0b013e318203a44d.
11. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 2008, 70:23-49. 10.1146/annurev.physiol.70.113006.100455.
12. Bidoggia H., Maciel J.P., Capalozza N., Mosca S., Blaksley E.J., Valverde E., Bertran G., Arini P., Biagetti M.O., Quinteiro R.A. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am. Heart J. 2000, 140:678-683. 10.1067/mhj.2000.109918.
13. Brado J., Dechant M.-J., Menza M., Komanscek A., Geiger J., Stiller B., Bode C., Jung B.A., Odening K.E. Phase contrast MRI reveals impaired diastolic relaxation and prolonged contraction duration in LQTS patients. Eur. Heart J. 2015, 36:P1429.
14. Brunner M., Peng X., Liu G.X., Ren X.-Q., Ziv O., Choi B.-R., Mathur R., Hajjiri M., Odening K.E., Steinberg E., Folco E.J., Pringa E., Centracchio J., Macharzina R.R., Donahay T., Schofield L., Rana N., Kirk M., Mitchell G.F., Poppas A., Zehender M., Koren G. Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J. Clin. Invest. 2008, 10.1172/JCI33578.
15. Bupha-Intr T., Wattanapermpool J. Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1101-H1108. 10.1152/ajpheart.00660.2005.
16. Castro-Torres Y., Carmona-Puerta R., Katholi R.E. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J. Clin. Cases 2015, 3:705-720. 10.12998/wjcc.v3.i8.705.
17. Cheng J. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human. Fundam. Clin. Pharmacol. 2006, 20:1-8. 10.1111/j.1472-8206.2005.00384.x.
18. Conrath C.E., Wilde A.A.M., Jongbloed R.J.E., Alders M., van Langen I.M., van Tintelen J.P., Doevendans P.A., Opthof T. Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. Cardiovasc. Res. 2002, 53:770-776.
19. Couderc J.-P., Xia X., Denjoy I., Extramiana F., Maison-Blanche P., Moss A.J., Zareba W., Lopes C.M. Genotype- and sex-specific QT-RR relationship in the Type-1 long-QT syndrome. J. Am. Heart Assoc. 2012, 1:e000570. 10.1161/JAHA.112.000570.
20. D'hooge J., Heimdal A., Jamal F., Kukulski T., Bijnens B., Rademakers F., Hatle L., Suetens P., Sutherland G.R. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur. J. Echocardiogr. 2000, 1:154-170. 10.1053/euje.2000.0031.
21. De Ferrari G.M., Nador F., Beria G., Sala S., Lotto A., Schwartz P.J. Effect of calcium channel block on the wall motion abnormality of the idiopathic long QT syndrome. Circulation 1994, 89:2126-2132.
22. Drici M.D., Burklow T.R., Haridasse V., Glazer R.I., Woosley R.L. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996, 94:1471-1474.
23. Foell D., Jung B., Germann E., Staehle F., Bode C., Markl M. Hypertensive heart disease: MR tissue phase mapping reveals altered left ventricular rotation and regional myocardial long-axis velocities. Eur. Radiol. 2013, 23:339-347. 10.1007/s00330-012-2613-0.
24. Foell D., Jung B.A., Germann E., Staehle F., Bode C., Hennig J., Markl M. Segmental myocardial velocities in dilated cardiomyopathy with and without left bundle branch block. J. Magn. Reson. Imaging 2013, 37:119-126. 10.1002/jmri.23803.
25. Foell D., Jung B., Germann E., Hennig J., Bode C., Markl M. Magnetic resonance tissue phase mapping: analysis of age-related and pathologically altered left ventricular radial and long-axis dyssynchrony. J. Magn. Reson. Imaging 2011, 34:518-525. 10.1002/jmri.22641.
26. Furukawa T., Kurokawa J. Non-genomic regulation of cardiac ion channels by sex hormones. Cardiovasc Hematol. Disord. Drug Targets 2008, 8:245-251.
27. Fülöp L., Bányász T., Szabó G., Tóth I.B., Bíró T., Lôrincz I., Balogh A., Petô K., Mikó I., Nánási P.P. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol. (Oxf) 2006, 188:163-171. 10.1111/j.1748-1716.2006.01618.x.
28. Goldenberg I., Zareba W., Moss A.J. Long QT syndrome. Curr. Probl. Cardiol. 2008, 33:629-694. 10.1016/j.cpcardiol.2008.07.002.
29. Haugaa K.H., Amlie J.P., Berge K.E., Leren T.P., Smiseth O.A., Edvardsen T. Transmural differences in myocardial contraction in long-QT syndrome: mechanical consequences of ion channel dysfunction. Circulation 2010, 122:1355-1363. 10.1161/CIRCULATIONAHA.110.960377.
30. Haugaa K.H., Edvardsen T. Myocardial contraction and long QT syndrome. Trends cardiovasc. Med. 2011, 21:65-69. 10.1016/j.tcm.2012.02.005.
31. Haugaa K.H., Edvardsen T., Leren T.P., Gran J.M., Smiseth O.A., Amlie J.P. Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome. Eur. Heart J. 2008, 30:330-337. 10.1093/eurheartj/ehn466.
32. Holmes J.W., Laksman Z., Gepstein L. Making better scar: emerging approaches for modifying mechanical and electrical properties following infarction and ablation. Prog. Biophys. Mol. Biol. 2016, 120(1-3):134-148.
33. January C.T., Riddle J.M. Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ. Res. 1989, 64:977-990.
34. Jung B., Föll D., Böttler P., Petersen S., Hennig J., Markl M. Detailed analysis of myocardial motion in volunteers and patients using high-temporal-resolution MR tissue phase mapping. J. Magn. Reson. Imaging 2006, 24:1033-1039. 10.1002/jmri.20703.
35. Jung B., Odening K.E., Armellina E.D., ll D.F., Menza M., Markl M., Schneider J.R.E. A quantitative comparison of regional myocardial motion in mice, rabbits and humans using in-vivo phase contrast CMR. J. Cardiovasc. Mag. Reson. 2012, 14. 1-1. 10.1186/1532-429X-14-87.
36. Kanters J.K., Haarmark C., Vedel-Larsen E., Andersen M.P., Graff C., Struijk J.J., Thomsen P.E.B., Christiansen M., Jensen H.K., Toft E. T(peak)T(end) interval in long QT syndrome. J. Electrocardiol. 2008, 41:603-608. 10.1016/j.jelectrocard.2008.07.024.
37. Keller J., Neužil P., Vymazal J., Janotka M., Brada J., Žáček R., Vopálka R., Weichet J., Reddy V.Y. Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator. Europace 2015, 17:761-766. 10.1093/europace/euu377.
38. Kurokawa J., Tamagawa M., Harada N., Honda S.-I., Bai C.-X., Nakaya H., Furukawa T. Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J. Physiol. 2008, 586:2961-2973. 10.1113/jphysiol.2007.150367.
39. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S.J., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 2005, Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography. 10.1016/j.echo.2005.10.005.
40. Lau E., Kossidas K., Kim T.Y., Kunitomo Y., Ziv O., Zhen S., Taylor C., Schofield L., Yammine J., Liu G., Peng X., Qu Z., Koren G., Choi B.-R. Spatially discordant alternans and arrhythmias in tachypacing-induced cardiac myopathy in transgenic LQT1 rabbits: the importance of IKs and Ca2+ cycling. PLoS One 2015, 10:e0122754. 10.1371/journal.pone.0122754.
41. Leren I.S., Hasselberg N.E., Saberniak J., Håland T.F., Kongsgård E., Smiseth O.A., Edvardsen T., Haugaa K.H. Cardiac mechanical alterations and genotype specific differences in subjects with long QT syndrome. JACC Cardiovasc Imaging 2015, 8:501-510. 10.1016/j.jcmg.2014.12.023.
42. Liu T., Choi B.-R., Drici M.-D., Salama G. Sex modulates the arrhythmogenic substrate in prepubertal rabbit hearts with Long QT 2. J. Cardiovasc Electrophysiol. 2005, 16:516-524. 10.1046/j.1540-8167.2005.40622.x.
43. Liu X.-K., Katchman A., Whitfield B.H., Wan G., Janowski E.M., Woosley R.L., Ebert S.N. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc. Res. 2003, 57:28-36.
44. Liu X.-K., Katchman A., Drici M.D., Ebert S.N., Ducic I., Morad M., Woosley R.L. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J. Pharmacol. Exp. Ther. 1998, 285:672-679.
45. Locati E.H., Zareba W., Moss A.J., Schwartz P.J., Vincent G.M., Lehmann M.H., Towbin J.A., Priori S.G., Napolitano C., Robinson J.L., Andrews M., Timothy K., Hall W.J. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998, 97:2237-2244.
46. Lubinski A., Lewicka-Nowak E., Kempa M., Baczynska A.M., Romanowska I., Swiatecka G. New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin. Electrophysiol. 1998, 21:172-175.
47. Marongiu M.L., Dimauro C. Preliminary study on factors influencing rabbit doe reproductive efficiency: effect of parity, day of mating, and suckling on ovarian status and estrogen levels at day 6 of pregnancy. Can. J. Vet. Res. 2013, 77:126-130.
48. Migdalovich D., Moss A.J., Lopes C.M., Costa J., Ouellet G., Barsheshet A., McNitt S., Polonsky S., Robinson J.L., Zareba W., Ackerman M.J., Benhorin J., Kaufman E.S., Platonov P.G., Shimizu W., Towbin J.A., Vincent G.M., Wilde A.A.M., Goldenberg I. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm 2011, 8:1537-1543. 10.1016/j.hrthm.2011.03.049.
49. Montaño L.M., Calixto E., Figueroa A., Flores-Soto E., Carbajal V., Perusquía M. Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade. Endocrinology 2008, 149:2517-2526. 10.1210/en.2007-1288.
50. Morita H., Wu J., Zipes D.P. The QT syndromes: long and short. Lancet 2008, 372:750-763. 10.1016/S0140-6736(08)61307-0.
51. Moss A.J. Long QT syndrome: from channels to cardiac arrhythmias. J. Clin. Invest. 2005, 115:2018-2024. 10.1172/JCI25537.
52. Moss A.J. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002, 105:794-799. 10.1161/hc0702.105124.
53. Nador F., Beria G., De Ferrari G.M., Stramba-Badiale M., Locati E.H., Lotto A., Schwartz P.J. Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications. Circulation 1991, 84:1530-1542.
54. Nakayama K., Yamanari H., Otsuka F., Fukushima K., Saito H., Fujimoto Y., Emori T., Matsubara H., Uchida S., Ohe T. Dispersion of regional wall motion abnormality in patients with long QT syndrome. Heart 1998, 80:245-250.
55. Napolitano C., Novelli V., Francis M.D., Priori S.G. Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact. Curr. Opin. Genet. Dev. 2015, 33:17-24. 10.1016/j.gde.2015.06.009.
56. Nerbonne J.M. Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J. Physiol. 2000, 525 Pt(2):285-298.
57. Odening K.E. Another jigsaw piece in the complex picture of hormonal regulation of cardiac repolarization. Eur. Heart J. 2015, ehv475. 10.1093/eurheartj/ehv475.
58. Odening K.E., Brunner M. Risk stratification in long QT syndrome: are we finally getting closer to a mutation-specific assessment of an individual patient's arrhythmogenic risk?. Heart Rhythm 2013, 10:726-727. 10.1016/j.hrthm.2013.02.008.
59. Odening K.E., Choi B.-R., Liu G.X., Hartmann K., Ziv O., Chaves L., Schofield L., Centracchio J., Zehender M., Peng X., Brunner M., Koren G. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm 2012, 9:823-832. 10.1016/j.hrthm.2012.01.009.
60. Odening K.E., Jung B.A., Lang C.N., Cabrera Lozoya R., Ziupa D., Menza M., Relan J., Franke G., Perez Feliz S., Koren G., Zehender M., Bode C., Brunner M., Sermesant M., Föll D. Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm 2013, 10:1533-1541. 10.1016/j.hrthm.2013.07.038.
61. Odening K.E., Kirk M., Brunner M., Ziv O., Lorvidhaya P., Liu G.X., Schofield L., Chaves L., Peng X., Zehender M., Choi B.R., Koren G. Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction. AJP Heart Circ. Physiol. 2010, 299:H643-H655. 10.1152/ajpheart.00074.2010.
62. Odening K.E., Koren G. How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. Heart Rhythm 2014, 11:2107-2115. 10.1016/j.hrthm.2014.06.023.
63. Ogawa M., Morita N., Tang L., Karagueuzian H.S., Weiss J.N., Lin S.-F., Chen P.-S. Mechanisms of recurrent ventricular fibrillation in a rabbit model of pacing-induced heart failure. Heart Rhythm 2009, 6:784-792. 10.1016/j.hrthm.2009.02.017.
64. Pfeiffer E.R., Tangney J.R., Omens J.H., McCulloch A.D. Biomechanics of cardiac electromechanical coupling and mechanoelectric feedback. J. Biomech. Eng. 2014, 136:021007. 10.1115/1.4026221.
65. Pham T.V., Rosen M.R. Sex, hormones, and repolarization. Cardiovasc. Res. 2002, 53:740-751.
66. Priori S. The long QT syndrome. Europace 2001, 3:16-27. 10.1053/eupc.2000.0141.
67. Priori S.G., Blomström-Lundqvist A.M., Mazzanti A., Blom N., Borggrefe M., Camm J., Perry M.E., Kirchhof P., Fitzsimons D., Hatala R., Hindricks G. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J. 2015, 36:2793-2867. 10.1093/eurheartj/ehv316.
68. Priori S.G., Chen S.R.W. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. Circ. Res. 2011, 108:871-883. 10.1161/CIRCRESAHA.110.226845.
69. Priori S.G., Napolitano C., Diehl L., Schwartz P.J. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994, 89:1681-1689.
70. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., Cappelletti D. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 2003, 348:1866-1874. 10.1056/NEJMoa022147.
71. Priori S.G., Wilde A.A., Horie M., Cho Y., Behr E.R., Berul C., Blom N., Brugada J., Chiang C.-E., Huikuri H., Kannankeril P., Krahn A., Leenhardt A., Moss A., Schwartz P.J., Shimizu W., Tomaselli G., Tracy C. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013, 10:1932-1963. 10.1016/j.hrthm.2013.05.014.
72. Rivero A., Curtis A.B. Sex differences in arrhythmias. Curr. Opin. Cardiol. 2010, 25:8-15. 10.1097/HCO.0b013e328333f95f.
73. Roden D.M. Clinical practice. Long-QT syndrome. N. Engl. J. Med. 2008, 358:169-176. 10.1056/NEJMcp0706513.
74. Sauer A.J., Moss A.J., McNitt S., Peterson D.R., Zareba W., Robinson J.L., Qi M., Goldenberg I., Hobbs J.B., Ackerman M.J., Benhorin J., Hall W.J., Kaufman E.S., Locati E.H., Napolitano C., Priori S.G., Schwartz P.J., Towbin J.A., Vincent G.M., Zhang L. Long QT syndrome in adults. J. Am. Coll. Cardiol. 2007, 49:329-337. 10.1016/j.jacc.2006.08.057.
75. Schwartz P.J. My approach to the long QT syndrome (LQTS). Trends Cardiovasc. Med. 2015, 25:376-377. 10.1016/j.tcm.2014.09.017.
76. Schwartz P.J., Ackerman M.J. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur. Heart J. 2013, 34:3109-3116. 10.1093/eurheartj/eht089.
77. Sims C., Reisenweber S., Viswanathan P.C., Choi B.-R., Walker W.H., Salama G. Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2. Circ. Res. 2008, 102:e86-100. 10.1161/CIRCRESAHA.108.173740.
78. Solovyova O., Katsnelson L.B., Kohl P., Panfilov A.V., Tsaturyan A.K., Tsyvian P.B. Mechano-electric heterogeneity of the myocardium as a paradigm of its function. Prog. Biophys. Mol. Biol. 2016, 120(1-3):249-254.
79. Stuyvers B.D., Miura M., Keurs ter H.E. Ca(2+)-dependence of passive properties of cardiac sarcomeres. Adv. Exp. Med. Biol. 2000, 481:353-366. discussion 367-70.
80. Tadros R., Ton A.-T., Fiset C., Nattel S. Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms. Can. J. Cardiol. 2014, 30:783-792. 10.1016/j.cjca.2014.03.032.
81. Terentyev D., Rees C.M., Li W., Cooper L.L., Jindal H.K., Peng X., Lu Y., Terentyeva R., Odening K.E., Daley J., Bist K., Choi B.-R., Karma A., Koren G. Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome. Circ. Res. 2014, 115:919-928. 10.1161/CIRCRESAHA.115.305146.
82. Terrenoire C., Clancy C.E., Cormier J.W., Sampson K.J., Kass R.S. Autonomic control of cardiac action potentials: role of potassium channel kinetics in response to sympathetic stimulation. Circ. Res. 2005, 96:e25-34. 10.1161/01.RES.0000160555.58046.9a.
83. Tester D.J., Ackerman M.J. Genetics of long QT syndrome. Methodist Debakey Cardiovasc. J. 2014, 10:29-33.
84. Tsang S., Wong S.S.C., Wu S., Kravtsov G.M., Wong T.-M. Testosterone-augmented contractile responses to alpha1- and beta1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart. Am. J. Physiol. Cell Physiol. 2009, 296:C766-C782. 10.1152/ajpcell.00193.2008.
85. Vijayakumar R., Silva J.N.A., Desouza K.A., Abraham R.L., Strom M., Sacher F., Van Hare G.F., Haïssaguerre M., Roden D.M., Rudy Y. Electrophysiologic substrate in congenital Long QT syndrome: noninvasive mapping with electrocardiographic imaging (ECGI). Circulation 2014, 130:1936-1943. 10.1161/CIRCULATIONAHA.114.011359.
86. Vyas H., O'Leary P.W., Earing M.G., Cetta F., Ackerman M.J. Mechanical dysfunction in extreme QT prolongation. J. Am. Soc. Echocardiogr. 2008, 21:511. e15-7. 10.1016/j.echo.2007.08.001.
87. 2+ channels via oestrogen-receptor- by a regional genomic mechanism in female rabbit hearts. J. Physiol. 2012, 590:493-508. 10.1113/jphysiol.2011.219501.
88. Zareba W., Bayes de Luna A. QT dynamics and variability. Ann. Noninvasive Electrocardiol. 2005, 10:256-262. 10.1111/j.1542-474X.2005.10205.x.
89. Zareba W., Moss A.J., Locati E.H., Lehmann M.H., Peterson D.R., Hall W.J., Schwartz P.J., Vincent G.M., Priori S.G., Benhorin J., Towbin J.A., Robinson J.L., Andrews M.L., Napolitano C., Timothy K., Zhang L., Medina A. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. JAC 2003, 42:103-109. International Long QT Syndrome Registry.
90. Ziv O., Morales E., Song Y.K., Peng X., Odening K.E., Buxton A.E., Karma A., Koren G., Choi B.R. Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome. J. Physiol. 2009, 587:4661-4680. 10.1113/jphysiol.2009.175018.